Edition:
United States

Invitae Corp (NVTA.N)

NVTA.N on New York Stock Exchange

16.72USD
21 Sep 2018
Change (% chg)

$-0.17 (-1.01%)
Prev Close
$16.89
Open
$16.90
Day's High
$17.25
Day's Low
$16.55
Volume
704,539
Avg. Vol
282,068
52-wk High
$18.38
52-wk Low
$4.35

Chart for

About

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016,... (more)

Overall

Beta: 1.76
Market Cap(Mil.): $1,166.22
Shares Outstanding(Mil.): 69.05
Dividend: --
Yield (%): --

Financials

  NVTA.N Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -1.54 -- --
ROI: -53.31 1.54 12.72
ROE: -84.43 0.30 14.84

BRIEF-Invitae Reports Q1 Loss Per Share $0.66

* INVITAE REPORTS 169% REVENUE GROWTH DRIVEN BY 150% GROWTH IN VOLUME IN FIRST QUARTER 2018

May 09 2018

BRIEF-Invitae Announces Pricing Of Public Offering Of Common Stock

* INVITAE ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

Mar 28 2018

BRIEF-Invitae Announces Proposed Public Offering Of Common Stock

* INVITAE CORP - ‍COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $50.0 MILLION OF SHARES OF ITS COMMON STOCK​ Source text for Eikon: Further company coverage:

Mar 26 2018

Earnings vs. Estimates